JPRN-UMIN000011598
Completed
N/A
Independent clinical study: Researching drug-drug interaction between aliskiren and sitagliptin - Independent clinical study
The University of Tokyo Hospital Unit for Early and Exploratory Clinical Development0 sites12 target enrollmentAugust 29, 2013
ConditionsHypertension
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- The University of Tokyo Hospital Unit for Early and Exploratory Clinical Development
- Enrollment
- 12
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •a) Had medical history of participation in other clinical trials or the clinical study accompanied by medicine medication within three months. b) Has hypotension (blood pressure of less than 100 mmHg during systole), hypertension (blood pressure of 140 mmHg or higher during systole) or diabetes (HbA1c NGSP 6\.5% or higher). c) Has donated or lost over 200 ml (1 unit) of blood within four weeks prior to study drug administration or 400 ml (2 units) within 3 months, or is anemic (less than Hb 12 g/dl). d) Has a serious neurological, cerebrovascular, hepatic, renal, endocrine, cardiovascular, digestive tract (including digestive tract disorders thought to impact trial drug absorption), respiratory, or metabolic disease in their medical history or as a concomitant condition. e) A clinically serious abnormality has been found by the principal investigator or one of the subinvestigators in the clinical test values, ECG or physical examination. f) Had a clinically serious illness within 30 days prior to study drug administration. g) Has used some sort of health food, or medical product within seven days prior to study drug administration or will use it during the study period. h) Has smoked tobacco, or ingested nicotine or alcohol within 30 days prior to study drug administration and, moreover, cannot abide by the prohibition on smoking and drinking during the study period. i) Tested positive for a specific abused substance (including alcohol) in the urine drug test at the screening. j) Anything else that the principal investigator or one of the subinvestigators considers to be disqualifying.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Independent study: Researching drug-drug interaction bitween etizolam and itraconazoleeurosis, somnipathyJPRN-UMIN000011279P-One Clinic, Keikokai Medical Corp16
Active, Not Recruiting
Phase 4
A study comparing two suture materials for graft preparation in knee ligament surgeryHealth Condition 1: M668- Spontaneous rupture of other tendonsCTRI/2021/09/036704Healthium Medtech Limited
Completed
Phase 4
A study comparing use of two surgical steel suture materials for closure of breastbone after cardiac surgeryHealth Condition 1: O- Medical and SurgicalCTRI/2020/10/028240Healthium Medtech Pvt Ltd72
Completed
Phase 4
Clinical equivalence study of two brands of polyester sutures (Trubond® and Ethibond) for fixation of the valvular prosthesis, in subjects undergoing aortic or mitral valve replacementHealth Condition 1: O- Medical and SurgicalCTRI/2020/04/024608Healthium Medtech Pvt Ltd formerly Sutures India Pvt Ltd88
Completed
N/A
A phase 1, open-label study to Investigate Drug-Drug Interaction (DDI) potential of Nipocalimab with coadministration of Etanercept or Hydroxychloroquine in healthy participants.NL-OMON49934Janssen-Cilag48